HSCS Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
2.1K
0
0
-100.0%
2.4K
+27.3%
1.9K
Cost of Revenue
760
0
0
-100.0%
1.0K
+32.6%
760
Gross Profit
1.3K
0
0
-100.0%
1.4K
+23.8%
1.1K
Operating Expenses
2.9M
+15.9%
2.5M
+31.5%
1.9M
-7.0%
2.1M
+10.6%
1.9M
R&D
906.6K
+90.4%
476.2K
-25.4%
638.6K
-12.2%
727.0K
-27.1%
997.2K
SG&A
2.0M
-1.3%
2.1M
+59.7%
1.3M
-4.3%
1.3M
+53.5%
878.1K
Operating Income
-2939090
-15.9%
-2536405
-31.5%
-1928940
+7.0%
-2073403
-10.6%
-1874119
EBITDA
-2932758
-15.9%
-2529647
-31.6%
-1922024
+7.0%
-2066397
-10.7%
-1867008
Net Income
-3172344
-15.3%
-2750904
-38.6%
-1985208
+15.6%
-2350769
-14.4%
-2054994
EPS (Basic)
$-0.86
-1.2%
$-0.85
-34.9%
$-0.63
+25.9%
$-0.85
+46.2%
$-1.58
EPS (Diluted)
$-0.86
-1.2%
$-0.85
-34.9%
$-0.63
+25.9%
$-0.85
+46.2%
$-1.58
Shares (Diluted)
3.7M
+12.7%
3.3M
+2.9%
3.2M
+13.7%
2.8M
+113.3%
1.3M
HeartSciences (HSCS) โ€” Financials